1. Introduction {#sec1}
===============

A growing body of evidence suggests a role of low-grade chronic inflammation in the development of type 2 diabetes. C-reactive protein (CRP) is a physiological marker of inflammation and reflects chronic inflammation when the concentration of this marker is slightly elevated over a longer period of time \[[@B1]\]. A meta-analysis of 16 prospective cohort studies showed that CRP was associated with an increased risk of type 2 diabetes \[[@B2]\]. This risk may be attributed to central adiposity \[[@B2]\]. It is also suggested that elements of the diet, like Glycemic Index (GI) and Glycemic Load (GL), may play a role \[[@B3]\]. The GI expresses the influence of foods on blood glucose concentrations after consumption \[[@B4]\]. The GL makes allowance for the GI of a food product and the portion size eaten \[[@B5]\]. At least four cross-sectional studies showed a positive association of GI or GL with CRP \[[@B6]--[@B9]\]. GI and GL have also been related to an increased risk of type 2 diabetes in several cohort studies \[[@B10]--[@B14]\], but not in all \[[@B15]--[@B18]\]. So, GI or GL diets may be of importance in the development of type 2 diabetes, possibly due to its effect on CRP concentrations.

We investigated, therefore, whether GI or GL is associated with CRP and subsequently with risk of type 2 diabetes in an elderly Dutch population. In this population a positive association between CRP and risk of type 2 diabetes was shown previously \[[@B19]\].

2. Materials and Methods {#sec2}
========================

2.1. Study Population {#sec2.1}
---------------------

The Rotterdam study is a population-based prospective cohort study among inhabitants of Ommoord, a district of the city Rotterdam, The Netherlands \[[@B20]\]. In 1990 all inhabitants of this district who were aged ≥55 years were invited for participation (*n* = 10,215). Of the 7,983 responders (78%), 2,548 participants did not provide sufficient dietary data, 516 had type 2 diabetes at baseline, and 553 had not sufficient information on follow-up time or covariates ([Figure 1](#fig1){ref-type="fig"}). Hence, 4,366 participants were included in the current analysis. The Medical Ethics Committee of Erasmus Medical Center, Rotterdam, The Netherlands, approved the study. All participants gave informed consent.

2.2. Data Collection {#sec2.2}
--------------------

### 2.2.1. Glycemic Index and Glycemic Load {#sec2.2.1}

Dietary assessment at baseline comprised a self-administered questionnaire followed by a structured interview with a trained dietician at the research centre. Participants had to mark the foods and drinks they had consumed at least twice a month in the preceding year. Subsequently, the dietician obtained accurate information on the amount of food eaten using a semiquantitative food frequency questionnaire \[[@B21]\]. Intake of food items was converted into total intake of energy and nutrients using the Dutch Food Composition table 1993 (NEVO). For the intake of fiber we used the Dutch Food Composition table 1996 (NEVO). Validation of the questionnaire against 15 multiple-day food records in 80 participants showed a Pearson\'s correlation of 0.79 for adjusted intake of total carbohydrates \[[@B21]\].

To each single food product derived from the questionnaire, GI values were assigned. These values were based on international published GI tables \[[@B22], [@B23]\]. Average GI and GL values for each participant were calculated as follows:

$$\begin{aligned}
{\text{Mean}{\,\,}\text{GI}} & {= \frac{\sum_{i = 1}^{n}\left( {\text{GI}_{i} \times \text{carbohydrates}_{i}} \right)}{\sum_{i = 1}^{n}\left( \text{carbohydrates}_{i} \right)},} \\
{\text{Mean}{\,\,}\text{GL}} & {= \frac{\sum_{i = 1}^{n}\left( {\text{GI}_{i}{\,\,} \times \text{carbohydrates}_{i}} \right)}{100}.} \\
\end{aligned}$$

GI*~i~* is the GI value of food product *i*. After mean GI and GL were calculated, mean GI and GL were adjusted for energy using the residual method \[[@B24]\].

### 2.2.2. C-Reactive Protein {#sec2.2.2}

Nonfasting serum blood samples were collected at baseline. In the samples, high-sensitivity CRP was measured using a rate near-infrared particle immunoassay (Immage Immuno-chemistry System, Beckman Coulter, Fullerton, CA). The procedure has been described in more detail elsewhere \[[@B19]\]. CRP concentrations exceeding 10 mg/L at baseline were excluded from the analysis of CRP, because these higher concentrations reflect rather acute than chronic inflammation \[[@B1]\].

### 2.2.3. Diabetes Incidence {#sec2.2.3}

*1990--1993 till 2005.*Participants were considered type 2 diabetes cases when they were registered by a general practitioner as having type 2 diabetes and had at least one of the following four criteria: plasma glucose concentration ≥7.0 mmol/L, random plasma glucose concentration ≥11.1 mmol/L, anti diabetes medication, treatment by diet. Diabetes cases were monitored until July 2005.

### 2.2.4. Nondietary Covariates {#sec2.2.4}

General information, for example, smoking status, education level, family history of type 2 diabetes, was obtained with a questionnaire at baseline. A family history of type 2 diabetes was defined as having a parent, sibling, or both with diabetes onset between 30 and 65 years. A history of coronary heart diseases (CHD) was defined as a self-reported myocardial infarction or angina pectoris with hospital admission. Information on energy expenditure (kcal/d) was obtained during follow-up for 3,244 participants of our study population with a physical activity questionnaire (LASA Physical Activity Questionnaire) \[[@B25]\]. Consequently, energy expenditure could be used as measure of physical activity in those participants. Information on anthropometrics was obtained during a visit at the research centre at baseline. Waist circumference was measured at the level midway between the lower rib margin and the iliac crest with participants in standing position. Blood pressure was measured twice at the right brachial artery with a random-zero sphygmomanometer with the participant in a sitting position. The mean of two consecutive measurements was used. High density lipoprotein (HDL) was measured with HDL cholesterol assay (Roche Diagnostics) using polyethylene glycol-modified enzymes and dextran sulfate.

2.3. Statistical Analysis {#sec2.3}
-------------------------

Descriptive data were expressed as a mean (SD), a median (interquartile range), or a percentage. In order to investigate the effect of GI or GL on the association between CRP and type 2 diabetes, our analysis included three steps.

Step 1The positive association between CRP and risk of type 2 diabetes, as shown previously in the Rotterdam Study (*n* = 5,901) \[[@B19]\], was verified in our subpopulation of the same study (*n* = 4,093) ([Figure 1](#fig1){ref-type="fig"}).

Step 2Linear regression models were used with energy-adjusted GI or GL as independent variable and CRP at baseline as dependent variable. CRP was transformed logarithmically to achieve a normal distribution. In addition to energy-adjusted GI or GL, model 1 included age (years), sex, smoking (current, former, never), and family history of diabetes (yes, no) as covariates. Model 2 was similar to model 1 with additional adjustment for intake of five dietary factors: energy (kcal/d), protein (energy-%), saturated fat (energy-%), alcohol (0, \>0--10, \>10--20, \>20 g/d), and fiber (g/d). Model 3 was similar to model 2 with additional adjustment for BMI (kg/m^2^).

Step 3We explored the association between energy-adjusted GI or GL and risk of type 2 diabetes using Cox proportional hazard models. Hazard Ratios (RR) and 95% CI provided by these Cox models expressed the risk relative to the lowest tertile. Model 1, model 2, and model 3 included the same covariates as used in [Step 2](#step2){ref-type="statement"}. To investigate a potential intermediate effect of CRP within the association of GI or GL with type 2 diabetes, an additional model was used. This model was similar to model 3 with additional adjustment for baseline lnCRP concentration.

In Steps [1](#step1){ref-type="statement"} and [3](#step3){ref-type="statement"}, we modeled the median value of each tertile of GI or GL as continuous variable to test for linear trends across categories. To investigate potential effect measure modification, the association between GI and GL and risk of type 2 diabetes was studied separately for men and women and for participants with a low and high BMI (median split: ≤25.9 versus \>25.9 kg/m^2^, resp.).

Analyses were carried out using the statistical software program SAS version 9.1. A two-sided *P* value less than  .05 was considered as statistically significant for all analysis.

3. Results {#sec3}
==========

At baseline, the mean of GI was 59 (SD 3) and mean GL was 127 (SD 22). The highest tertile of GI included more smokers and more men than the lowest tertile ([Table 1](#tab1){ref-type="table"}). Intake of polysacharides increased, whereas intake of mono- and disaccharides and fiber decreased across tertiles of GI. Using stepwise regression, the main contributors to the variation in energy-adjusted GL appeared to be sweets (26%), fats (9%), bread (9%), alcoholic drinks (7%), and nuts (5%). The main contributors to the variation in energy-adjusted GI were milk products (28%), fruit (20%), bread (13%), potatoes (5%), and cakes (2%). Median CRP concentration was 1.65 mg/L, and 1,097 (25%) participants had an elevated CRP level (\>3 mg/L) at baseline.

[Step 1](#step1){ref-type="statement"} of our analysis included 4,093 participants of whom 423 developed type 2 diabetes during a median follow-up time of 11.0 years. The analysis confirmed that CRP at baseline was associated with an increased risk of type 2 diabetes after adjustment for age, sex, BMI, waist, systolic blood pressure, diastolic blood pressure, and HDL (RR~CRP  Q4  versus  Q1~: 1.76 (95%CI 1.27, 2.45); *P* ~trend~ \< .01). This RR was in line with RRs found when adjusted additionally for GI or GL (RR~CRP  Q4  versus  Q1~: 1.76 (95%CI 1.27, 2.43); RR~CRP  Q4  versus  Q1~: 1.76 (95%CI 1.27, 2.44), resp.). The association did not differ considerably between participants with a low or high GI diet (*P* ~interaction~ = .53) and between participants with a low or high GL diet (*P* ~interaction~ = .99).

[Step 2](#step2){ref-type="statement"} of our analysis showed that after adjustment for lifestyle factors, nutritional factors, and BMI, a 50 unit increase in GL was associated with a 12% higher CRP concentration at baseline (*P* = .01) ([Table 2](#tab2){ref-type="table"}). No association was observed for a 10 unit increase in GI (*b* = 0, *P* = .90).

[Step 3](#step3){ref-type="statement"} of our analysis included 4,366 participants whose median follow-up was 12.4 years. A number of 456 participants developed type 2 diabetes. When comparing the highest to the lowest tertile in this population, an adjusted RR of 0.95 (95%CI 0.75, 1.21) was found for GI (model 3) ([Table 3](#tab3){ref-type="table"}). For GL this adjusted RR~T~3~  versus  T~1~~ was 1.00 (95%CI 0.74, 1.36). So, GI and GL were not associated with the risk of type 2 diabetes in this study. The RR found for GL was comparable with the one found for the association between intake of total carbohydrates and risk of type 2 diabetes (*Model 3*RR~Q4  versus  Q1~: 1.04 (95%CI 0.71, 1.53)). The similar results also reflect the high correlation between total carbohydrates and GL (*r* = 0.93). After adding CRP at baseline to model 3, RRs for risk of type 2 diabetes did not change considerably (RR~GI  T~3~  versus  T~1~~: 0.96 (95%CI 0.75, 1.22); RR~GL  T~3~  versus  T~1~~: 0.99 (95%CI 0.73, 1.35)) ([Table 3](#tab3){ref-type="table"}). In those with available information on physical activity, additional adjustment for energy expenditure did not change the RRs considerably (data not shown).

The association between GI or GL and risk of type 2 diabetes did not differ considerably between men and women (Model 3: *P* ~interaction  GI~ = .75; *P* ~interaction  GL~ = .08) and between participants with a low and high BMI (Model 3: *P* ~interaction  GI~ = .32; *P* ~interaction  GL~ = .29). Exclusion of participants with CHD at baseline (*n* = 514) did not substantially change the results (*Model 3*RR~GI  T~3~  versus  T~1~~: 0.93 (95%CI 0.72, 1.21); RR~GL  T~3~  versus  T~1~~: 1.03 (95%CI 0.74, 1.43)).

4. Discussion {#sec4}
=============

In this Dutch population, GL was associated positively with CRP at baseline, but not with risk of type 2 diabetes. GI was not associated with CRP nor with risk of type 2 diabetes. A high GI diet, therefore, could not explain the positive association between CRP and risk of type 2 diabetes by increasing CRP concentrations.

We were able to study how GI and GL were associated with CRP and type 2 diabetes in a prospective cohort study with a high response rate, with a long follow-up period, with confirmed diabetes cases, and with available information on CRP concentration at baseline of a large population.

Our FFQ measured adequately intake of carbohydrates, which was correlated highly with GL, but was not designed to measure GI or GL. It could be, therefore, that food products with a very high or low GI were not taken into account. This might explain the small range in GI and GL in our study. A comparable range in GI, however, was also observed in other Dutch cohorts in whom another FFQ was used \[[@B8], [@B26]\]. In one of the cohorts even a smaller range was found when GI was based on twelve 24-hr recalls instead of on a FFQ \[[@B26]\]. This shows that a small range in GI may exist in the Netherlands. National data on GI values of Dutch food products, however, would have provided more accurate measure of GI.

GL, but not GI, was associated positively with CRP at baseline in this study. Due to the high correlation between GL and intake of carbohydrates in our population, the effect of GL itself could not be separated from the effect of total carbohydrate intake. Other cross-sectional studies on the association with CRP observed either positive associations for high GL diet \[[@B6]\] or high GI diet \[[@B7]--[@B9]\] or no association for GI \[[@B6], [@B27]--[@B29]\] or GL \[[@B7]--[@B9], [@B28]--[@B30]\]. No associations were also observed between changes in GI or GL and changes in CRP in a longitudinal study with a one-year follow-up \[[@B27]\]. On the contrary, one randomized trial in participants with type 2 diabetes showed that reduction in CRP concentration after 1 year was more pronounced in a low GI diet than a high GI diet \[[@B31]\]. Other randomized trials with a shorter duration, however, did not observe differential effects on CRP between a low GI diet and a high GI diet independently of weight lost \[[@B32]--[@B37]\]. Taking these results together, it is not very likely that GI affects CRP concentrations. The high within person variation in CRP, however, could have reduced the power of the statistical tests of the beta-coefficient \[[@B38], [@B39]\]. Therefore, duplicate measures of CRP should be used in new studies.

Our findings concerning the association of GI or GL with risk of type 2 diabetes are not in line with the conclusion of a meta-analysis published in 2008 \[[@B10]\]. This meta-analysis on five cohort studies showed that high GI or GL diets were associated with an increased risk of type 2 diabetes (RR~GI~ 1.40 (95%CI 1.23, 1.59); RR~GL~ 1.27 (95%CI 1.12, 1.45)). After this meta-analysis, these associations were investigated additionally in eight cohort studies. These studies found associations of GI with risk of type 2 diabetes ranging from a 6% lower risk to a 50% higher risk \[[@B11], [@B13]--[@B18]\]; with two of them statistically significant \[[@B11], [@B13]\]. The associations of GL with risk of type 2 diabetes ranged from a 20% lower risk to a 41% higher risk \[[@B11]--[@B17]\]. Three studies reported that their findings were statistically significant in women \[[@B12], [@B13]\] or in both sexes \[[@B14]\]. Four of these newly published studies \[[@B12]--[@B15]\] and our study met the inclusion criteria used in the meta-analysis by Barclay et al. \[[@B10]\]. Since ranges in GI do not always overlap among studies, a new pooled risk estimate would be difficult to interpret. Studies with high GI values (median of lowest category \>63) observed higher risks of type 2 diabetes \[[@B5], [@B40], [@B41]\], whereas studies with low GI values (median of highest category \<63) did not observe associations with type 2 diabetes \[[@B14], [@B15]\]. Our study gives additional information about the association between lower ranges of GI values and risk of type 2 diabetes, which was lacking in the meta-analysis. Overall, this might suggest that only high GI values are associated adversely with risk of type 2 diabetes.

5. Conclusion {#sec5}
=============

Both GI and GL were not associated with risk of type 2 diabetes, although GL was associated positively with CRP concentrations. It is, therefore, unlikely that a high GI diet induces the positive association between CRP and risk of type 2 diabetes by increasing CRP concentrations.
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###### 

Baseline characteristics of 4,366 Dutch adults aged ≥55 years by tertiles of energy-adjusted glycemic index (GI).^1^

                                        Low GI (\<57.6)   Moderate GI (57.6--\<60.3)   High GI (≥60.3)
  ------------------------------------- ----------------- ---------------------------- -----------------
  Age (years)                           67.3 (7.9)        67.7 (7.7)                   66.9 (7.4)
  Sex (% male)                          26.6              39.7                         54.5
  Body Mass Index (kg/m^2^)             26.5 (3.6)        26.2 (3.4)                   26.0 (3.8)
  C-reactive protein (mg/L)^2^          1.6 (0.80--2.9)   1.7 (0.83--3.0)              1.7 (0.83--3.1)
  Anti-inflammatory medication (%)      8.0               6.6                          7.7
  Family history of diabetes (%)        26.5              26.8                         29.7
  History of CHD (%)                    10.0              11.9                         13.4
  Smoking (% current)                   15.8              20.4                         32.0
  Education level (% low)               33.6              33.5                         35.7
  *Dietary intake*                                                                     
  Total energy (kcal/d)                 1967 (555)        2005 (491)                   1971 (464)
  Carbohydrate (en%)                    44.2 (6.6)        44.7 (6.6)                   43.7 (7.6)
   Mono- and disacharides (en%)         24.5 (5.7)        22.6 (5.5)                   19.7 (6.5)
   Polysacharides (en%)                 19.7 (3.7)        22.0 (3.7)                   23.7 (4.4)
  Energy-adjusted glycemic load         119 (19.0)        128 (20.1)                   133 (23.1)
  Fiber (g/d)                           27.1 (8.3)        26.3 (6.4)                   25.1 (6.6)
  Protein (en%)                         18.0 (3.3)        16.7 (2.8)                   16.2 (2.8)
  Fat (en%)                             35.9 (6.3)        36.5 (6.1)                   37.3 (6.2)
   Saturated fatty acids (en%)          14.3 (3.4)        14.4 (3.1)                   14.6 (3.1)
   Mono-unsaturated fatty acids (en%)   12.3 (2.7)        12.3 (2.7)                   12.6 (2.8)
   Poly-unsaturated fatty acids (en%)   6.5 (2.8)         7.0 (2.8)                    7.3 (2.9)
  Alcohol drinkers (%)                  79.2              82.2                         79.9
   Alcohol (g/d)^2,3^                   6.0 (1.3--15.7)   6.4 (1.4--16.3)              8.7 (1.8--21.8)

^1^Means (SD) or percentages unless otherwise indicated.

^2^Values are expressed as median (interquartile range), because of their skewed distribution.

^3^Only in alcohol drinkers.

###### 

Beta coefficients (SEE) for the association of energy-adjusted glycemic index (GI) or glycemic load (GL) with ln-C-reactive protein (CRP) in Dutch adults aged ≥55 years.

                Ln-CRP at baseline        
  ------------- ------------------------- -------------------------
                *GI per 10 units*         *GL per 50 units*
  Crude model   0.11 (0.04), *P* \< .01   −0.04 (0.03), *P* = .25
  Model 1       0.04 (0.04), *P* = .31    −0.03 (0.03), *P* = .41
  Model 2       0.05 (0.04), *P* = .29     0.09 (0.05), *P* = .05
  Model 3       0.005 (0.04), *P* = .90    0.11 (0.04), *P* = .01

Values are beta-coefficients with SEE.

Model 1: adjusted for age, sex, smoking, and family history of diabetes.

Model 2: as model 1 with additional adjustments for intake of energy, protein, saturated fat, alcohol, and fiber.

Model 3: as model 2 with additional adjustment for BMI.

###### 

Relative risks (95%CI) for incident type 2 diabetes by tertiles of energy-adjusted glycemic index and glycemic load in 4,366 Dutch adults aged ≥55 years.

                    Low         Moderate            High                *P* for trend
  ----------------- ----------- ------------------- ------------------- ---------------
  Glycemic index    (\<57.6)    (≥57.6--\<60.3)     (≥60.3)             
   Median           55.7        58.9                62.1                
   \# cases/total   149/1,455   141/1,456           166/1,455           
   Person years     16,227      16,023              15,691              
   Crude model      1           0.96 (0.76, 1.21)   1.16 (0.93, 1.44)   .19
   Model 1          1           0.91 (0.72, 1.15)   1.02 (0.81, 1.29)   .84
   Model 2          1           0.96 (0.76, 1.22)   1.06 (0.83, 1.35)   .64
   Model 3          1           0.94 (0.74, 1.19)   0.95 (0.75, 1.21)   .71
   Model 4          1           0.92 (0.73, 1.17)   0.96 (0.75, 1.22)   .75
  Glycemic load     (\<117.6)   (≥117.6--\<134.6)   (≥134.6)            
   Median           107.1       126.4               146.1               
   \# cases/total   173/1,455   149/1,456           134/1,455           
   Person years     15,825      16,206              15,910              
   Crude model      1           0.83 (0.67, 1.03)   0.77 (0.61, 0.96)   .02
   Model 1          1           0.86 (0.69, 1.07)   0.77 (0.61, 0.96)   .02
   Model 2          1           0.92 (0.72, 1.17)   0.98 (0.72, 1.33)   .86
   Model 3          1           0.91 (0.71, 1.16)   1.00 (0.74, 1.36)   .96
   Model 4          1           0.90 (0.70, 1.15)   0.99 (0.73, 1.35)   .91

Model 1: adjusted for age, sex, smoking, and family history of diabetes.

Model 2: as model 1 with additional adjustments for intake of energy, protein, saturated fat, alcohol, and fiber.

Model 3: as model 2 with additional adjustment for BMI.

Model 4: as model 3 with additional adjustment for ln C-reactive protein.
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